Hesperidin is a citrus flavonoid, but the form brands actually ask for is rarely plain hesperidin. Japan mostly uses glucosyl hesperidin (also called monoglucosyl hesperidin or α-glucosylhesperidin), a version with one glucose molecule attached to make it dissolve in water. Brands abroad hear about it through Japanese cold-season drinks and tablets and ask for the same ingredient.
This guide is for brand owners planning a glucosyl hesperidin product made in Japan. It covers what the human trials show, how Japan frames the ingredient under its function-claims system, how it is usually formulated, and what to fix before asking for a quotation.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a hesperidin product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
Small Japanese human trials report that glucosyl hesperidin helps maintain peripheral blood flow and skin temperature under cold conditions, while a larger 2026 industry-funded trial on lymphatic circulation found an effect only in a subgroup.
| Study | Design | Reported result |
|---|---|---|
| Takumi et al., Bioscience, Biotechnology, and Biochemistry 2010, 74(4):707-715 (PMID 20378967) | Three linked experiments in healthy adults on alpha-glucosylhesperidin (G-Hsp) and peripheral body temperature, including a 500 mg dose under 24°C ambient conditions and heart-rate-variability measurement | 500 mg G-Hsp limited the drop in peripheral (fingertip) temperature under cool ambient conditions; a G-Hsp beverage kept fingers warmer for longer; heart-rate-variability data suggested a shift in autonomic nervous system balance alongside the temperature effect |
| Randomised, placebo-controlled, double-blind, crossover trial, Scientific Reports 2026, 16:18010 (PMID 42270667, DOI 10.1038/s41598-026-36166-1) | 30 healthy adults (29 completed), monoglucosyl hesperidin 300 mg/day for a defined period, thoracic duct diameter measured by ultrasound as a marker of lymphatic circulation | No significant change across the whole group; among participants with no regular exercise habit, thoracic duct diameter significantly increased or showed a trend toward increase versus placebo |
Two points to keep in view:
- Size and age of the evidence. The 2010 study is small and over a decade old; a positive peripheral-temperature result from one research group is not the same as a large independent replication.
- Funding and mixed result. The 2026 trial was run under a joint research agreement between a university and a beverage and food company, and its headline result held only in a subgroup, not the full study population. Read the funding line and the subgroup caveat of any study you plan to cite.
Checked against the published abstracts on 25 September 2026.
What Japanese products say
In Japan, monoglucosyl hesperidin is a common Foods with Function Claims ingredient notified for maintaining peripheral blood flow and peripheral body temperature when the surrounding temperature is low, such as in winter or under air conditioning.
Under Japan’s Foods with Function Claims system, the notifying business is responsible for the scientific evidence behind the stated function, submitted to the Consumer Affairs Agency before sale. Typical notified wording describes an everyday, weather-related state — blood flow and temperature in the hands and feet during cold conditions — not a circulation disorder or any medical diagnosis.
Two lessons for a brand abroad:
- The Japanese wording stays functional, not medical. It refers to peripheral blood flow and peripheral body temperature in cold conditions, never to a circulatory disease or to “cold hands and feet” as a condition to be treated.
- A Japanese notification is not a global endorsement. It is a Japanese regulatory mechanism for products sold in Japan. Your label abroad follows your own market’s rules, and the evidence base for this specific claim is still thin by international standards.
💬 Need an evidence summary for your regulatory adviser that separates Japanese notifications from independent trial data? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe hesperidin by the blood-flow-related marker studied, never as a treatment for a circulation condition.
| Safer wording | Wording to avoid |
|---|---|
| ”Studied for peripheral blood flow and skin temperature in cool conditions" | "Treats cold hands and feet”, or any circulation-disorder name |
| ”Contains glucosyl hesperidin” with the amount per serving | ”Clinically proven” without naming the study and its limits |
| Noting the funding and subgroup result of the 2026 trial when citing it | Presenting the 2026 result as if it applied to the whole study group |
How hesperidin is formulated
Plain hesperidin barely dissolves in water, so Japan almost always uses glucosyl hesperidin, which is far more water-soluble and fits liquid and powder formats as easily as tablets.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Tablet or hard capsule | Simple, low cost per serving | Straightforward for combined formulas |
| Drink or beverage | Matches how glucosyl hesperidin is marketed in Japan, especially for cold-season products | Taste and stability in the finished liquid |
| Powder stick | Dissolves easily because of the glucosyl form’s water solubility | Packaging and taste masking |
| Confectionery (tablet sweets) | A familiar Japanese cold-season format | Sugar content and your market’s rules on supplement-like foods |
Decisions that shape the specification:
- Form, not just the name. “Hesperidin” and “glucosyl hesperidin” are not interchangeable in formulation terms. A 2024 in vitro comparison reported octanol-water partition coefficients (log P) of 2.13 for hesperidin and −3.45 for hesperidin glucoside — the negative value means the glucosylated form is markedly more water-soluble. Specify the glucosylated form if the dosage form is a drink or powder.
- Amount per serving. Match the amount to any study you intend to cite — for example 300 mg/day of monoglucosyl hesperidin in the 2026 lymphatic-circulation trial, or the 500 mg single dose used in the 2010 peripheral-temperature study.
- Companion ingredients. Glucosyl hesperidin is often combined with other cold-season or beauty ingredients. Each companion needs its own check against Japanese food law.
- Your market’s status for hesperidin. Its status as a food supplement ingredient differs between countries. Confirm it before you commit to a formula.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Glucosyl hesperidin itself is widely used in Japanese foods and drinks. Cold-season and beauty combination formulas are where companion botanicals most often cause a problem. A formula that could not be sold as a food in Japan cannot be made as one there, and cannot obtain a Japanese Certificate of Free Sale. See the Japan-made supplement OEM page, and compare with our hyaluronic acid and collagen peptide guides.
Before you ask for a quotation
A factory can quote accurately once the form, the amount, the companions and the packaging are fixed.
- Hesperidin form (plain hesperidin or glucosyl/monoglucosyl hesperidin) and specification
- Amount per serving and servings per pack
- Dosage form
- Companion ingredients and their amounts
- Packaging
- Countries you will sell in, and first order and annual volume
💬 Ready to design a Japan-made hesperidin product? Send us the concept — form, amount, dosage form and the countries you will sell in.
Frequently asked questions
1. Is glucosyl hesperidin the same as hesperidin?
No. Glucosyl hesperidin is hesperidin with a glucose molecule attached, made to dissolve in water. A 2024 comparison reported a large difference in water solubility between the two forms, which is why Japanese products almost always use the glucosylated version.
2. What has glucosyl hesperidin actually been studied for?
Small Japanese human trials have looked at peripheral blood flow and skin temperature under cool conditions. A 2010 study reported a temperature effect from a 500 mg dose, and a 2026 trial on lymphatic circulation found an effect only in participants without a regular exercise habit, not across the whole group.
3. Does Japan allow a blood-flow claim for this ingredient?
Monoglucosyl hesperidin has been notified under Japan’s Foods with Function Claims system for maintaining peripheral blood flow and peripheral body temperature in cold conditions. That wording describes an everyday, weather-related state, not a circulation disorder, and it is a Japanese mechanism for products sold in Japan.
4. Which dosage form suits hesperidin best?
Glucosyl hesperidin’s water solubility means it works in drinks and powders as well as tablets and capsules — unlike plain hesperidin, which is poorly soluble and harder to use in liquid formats.
5. What can stop a Japanese factory making my hesperidin product?
Usually a companion ingredient, not hesperidin itself. Every ingredient in the formula must be permitted in foods in Japan, so we check the full formula first.
Sources: “Effects of alpha-glucosylhesperidin on the peripheral body temperature and autonomic nervous system”, Bioscience, Biotechnology, and Biochemistry 2010, 74(4):707-715 (PMID 20378967); “Effects of monoglucosyl hesperidin on human lymphatic circulatory function: A randomized placebo-controlled, double-blind, crossover trial”, Scientific Reports 2026, 16:18010 (PMID 42270667, DOI 10.1038/s41598-026-36166-1); “In Vitro Biological Activities of Hesperidin-Related Compounds with Different Solubility”, Antioxidants (Basel) 2024 (PMID 38929166, DOI 10.3390/antiox13060727); Consumer Affairs Agency notifications for Foods with Function Claims. Checked on 25 September 2026.